rs142411476

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_024915.4(GRHL2):​c.548G>A​(p.Arg183Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000203 in 1,614,158 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00015 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00021 ( 0 hom. )

Consequence

GRHL2
NM_024915.4 missense

Scores

6
13

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 5.22

Publications

4 publications found
Variant links:
Genes affected
GRHL2 (HGNC:2799): (grainyhead like transcription factor 2) The protein encoded by this gene is a transcription factor that can act as a homodimer or as a heterodimer with either GRHL1 or GRHL3. Defects in this gene are a cause of non-syndromic sensorineural deafness autosomal dominant type 28 (DFNA28).[provided by RefSeq, Mar 2009]
GRHL2 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 28
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: STRONG Submitted by: ClinGen
  • posterior polymorphous corneal dystrophy
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, G2P
  • nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital fibrosis of extraocular muscles
    Inheritance: Unknown Classification: LIMITED Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.08277768).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRHL2NM_024915.4 linkc.548G>A p.Arg183Gln missense_variant Exon 4 of 16 ENST00000646743.1 NP_079191.2 Q6ISB3-1
GRHL2NM_001330593.2 linkc.500G>A p.Arg167Gln missense_variant Exon 4 of 16 NP_001317522.1 Q6ISB3-2B4DL28
GRHL2NM_001440448.1 linkc.500G>A p.Arg167Gln missense_variant Exon 4 of 16 NP_001427377.1
GRHL2NM_001440447.1 linkc.548G>A p.Arg183Gln missense_variant Exon 4 of 16 NP_001427376.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRHL2ENST00000646743.1 linkc.548G>A p.Arg183Gln missense_variant Exon 4 of 16 NM_024915.4 ENSP00000495564.1 Q6ISB3-1
GRHL2ENST00000395927.1 linkc.500G>A p.Arg167Gln missense_variant Exon 4 of 16 2 ENSP00000379260.1 Q6ISB3-2

Frequencies

GnomAD3 genomes
AF:
0.000151
AC:
23
AN:
152146
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.000660
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000206
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000235
AC:
59
AN:
251330
AF XY:
0.000250
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000139
Gnomad NFE exome
AF:
0.000405
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000208
AC:
304
AN:
1461894
Hom.:
0
Cov.:
33
AF XY:
0.000231
AC XY:
168
AN XY:
727248
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000209
AC:
18
AN:
86258
European-Finnish (FIN)
AF:
0.000337
AC:
18
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.000231
AC:
257
AN:
1112012
Other (OTH)
AF:
0.000166
AC:
10
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
19
38
56
75
94
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000151
AC:
23
AN:
152264
Hom.:
0
Cov.:
31
AF XY:
0.000175
AC XY:
13
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41542
American (AMR)
AF:
0.00
AC:
0
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4822
European-Finnish (FIN)
AF:
0.000660
AC:
7
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000206
AC:
14
AN:
68018
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000297
Hom.:
0
Bravo
AF:
0.000128
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.000288
AC:
35
EpiCase
AF:
0.000382
EpiControl
AF:
0.000237

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:2
Jun 12, 2025
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis suggests that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign in association with GRHL2-related disorders to our knowledge; This variant is associated with the following publications: (PMID: 36596879) -

Jun 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 183 of the GRHL2 protein (p.Arg183Gln). This variant is present in population databases (rs142411476, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with GRHL2-related conditions. ClinVar contains an entry for this variant (Variation ID: 178378). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt GRHL2 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not specified Uncertain:1
Nov 12, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant classified as Uncertain Significance - Favor Benign. The p.Arg183Gln var iant in GRHL2 has been identified by our laboratory in one individual with heari ng loss, but did not segregate with the disease in an affected relative (LMM unp ublished data). It has been identified in 27/66684 European chromosomes by the E xome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs14241 1476). Computational prediction tools and conservation analysis suggest that the p.Arg183Gln variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, while the clinical sign ificance of the p.Arg183Gln variant is uncertain, these data suggest that it is more likely to be benign. -

Autosomal dominant nonsyndromic hearing loss 28;C4014987:Nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome;C4747961:Corneal dystrophy, posterior polymorphous, 4 Uncertain:1
Oct 21, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.095
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.45
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.090
T;T;.
Eigen
Uncertain
0.35
Eigen_PC
Uncertain
0.39
FATHMM_MKL
Uncertain
0.80
D
LIST_S2
Uncertain
0.95
.;D;D
M_CAP
Benign
0.0094
T
MetaRNN
Benign
0.083
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.6
L;L;.
PhyloP100
5.2
PrimateAI
Uncertain
0.50
T
PROVEAN
Benign
-0.78
N;.;N
REVEL
Benign
0.12
Sift
Benign
0.30
T;.;T
Sift4G
Benign
0.63
T;.;T
Polyphen
0.90
P;P;.
Vest4
0.48
MVP
0.13
MPC
0.57
ClinPred
0.10
T
GERP RS
5.3
Varity_R
0.084
gMVP
0.55
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142411476; hg19: chr8-102570910; COSMIC: COSV52547381; COSMIC: COSV52547381; API